Skip to main content

Important information

The contents of this webpage are in French only.

Find out whether a drug is covered

Over 8,000 prescription drugs are covered under the Public Prescription Drug Insurance Plan. They are included on a regularly updated list. Other drugs not on the list may also be covered on an exceptional basis.

Prescription drug search

Disclaimer : Search results do not have the same value as a legal document. To access the relevant legal document, please refer to the List of Medications.

Bimzelx

Exceptional medication
  • Active ingredient(s):
  • Manufactured by:
    U.C.B. Pharma Canada Inc. (U.C.B.)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution syringe 160 mg/mL (1 mL) DIN : 2525267
    • Subcutaneous Injectable Solution syringe 160 mg /mL (2 mL) DIN : 2553619
    • Subcutaneous Injectable Solution (pen) 160 mg/mL (1 mL) DIN : 2525275
    • Subcutaneous Injectable Solution (pen) 160 mg /mL (2 mL) DIN : 2553627

JAMP Cabergoline

Exceptional medication
  • Active ingredient(s):
  • Manufactured by:
    Jamp Pharma Corporation (Jamp)
  • Strength and dosage form:
    Tablet 0.5 mg DIN : 2549611

Ixifi

Exceptional medication
  • Active ingredient(s):
  • Manufactured by:
    Pfizer Canada Inc. (Pfizer)
  • Strength and dosage form:
    Intravenous or Perfusion Powder 100 mg DIN : 2523191

Remdantry

Exceptional medication
  • Active ingredient(s):
  • Manufactured by:
    Celltrion Healthcare Canada Limited (Celltrion)
  • Strength and dosage form:
    Intravenous or Perfusion Powder 100 mg DIN : 2419475

Apo-Nilotinib

Exceptional medication
  • Active ingredient(s):
  • Manufactured by:
    Apotex Inc. (Apotex)
  • Strength and dosage form:
    • Capsule 150 mg DIN : 2550881
    • Capsule 200 mg DIN : 2550903

M-Pirfenidone

Exceptional medication
  • Active ingredient(s):
  • Manufactured by:
    Mantra Pharma inc. (Mantra Ph.)
  • Strength and dosage form:
    • Tablet 267 mg DIN : 2550644
    • Tablet 801 mg DIN : 2550652

Tyenne

Exceptional medication
  • Active ingredient(s):
  • Manufactured by:
    Fresenius Kabi Canada Ltd. (Fresenius)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution syringe 162 mg/0.9 mL DIN : 2552493
    • Intravenous Perfusion Solution 20 mg/mL (10 mL) DIN : 2552469
    • Intravenous Perfusion Solution 20 mg/mL (20 mL) DIN : 2552477
    • Intravenous Perfusion Solution 20 mg/mL (4 mL) DIN : 2552450
    • Subcutaneous Injectable Solution (pen) 162 mg/0.9 mL DIN : 2552485

Epidiolex

Exceptional medication
  • Active ingredient(s):
  • Manufactured by:
    Jazz Pharmaceuticals Canada (Jazz)
  • Strength and dosage form:
    Oral Solution 100 mg /mL (100 mL) DIN : 2543079

Xcopri

Exceptional medication
  • Active ingredient(s):
  • Manufactured by:
    Laboratoires Paladin Inc. (Paladin)
  • Strength and dosage form:
    • Tablet 100 mg DIN : 2538733
    • Tablet 12.5 mg DIN : 2538652
    • Tablet 150 mg DIN : 2538741
    • Tablet 200 mg DIN : 2538768
    • Tablet 25 mg DIN : 2538660
    • Tablet 50 mg DIN : 2538725

Xcopri (Starter Kit)

Exceptional medication
  • Active ingredient(s):
  • Manufactured by:
    Laboratoires Paladin Inc. (Paladin)
  • Strength and dosage form:
    • Tablet 12,5 mg (14 co.) - 25 mg (14 co.) DIN : 2538776
    • Tablet 150 mg (14 co.) - 200 mg (14 co.) DIN : 2538792
    • Tablet 50 mg (14 co.) - 100 mg (14 co.) DIN : 2538784

How did we do?

Was the information on this page useful to you?
Do not include any personal information. You will not receive any reply.